Welcome to SELECTBIO

SELECTBIO provides focused market reports, custom consultancy, recruitment, training courses and conferences to the life science marketplace. Specialising in early stage drug discovery and omics, we provide open forums for learning and networking, with the aim of fostering discussion and debate to advance disease research.

Conferences	Business Courses	Training Courses

Our specialist portfolio of global life science events provide attendees with a rich learning and networking environment where they can share and discuss the latest developments in their field. Ideal for professionals working in industry and academic settings within life science.	SELECTBIO business courses provide attendees with an up-to-date analysis of the life sciences, diagnostics and pharma-discovery space. Ideal for people involved in business planning processes and for those wishing to research and understand new market opportunities.	Keep up to date with emerging research techniques, technology developments and regulatory changes by attending one of our short courses or workshops.

Customer Testimonials

"A great focussed meeting, with attendees interested in our products. Very well organised at registration and during the course of the meeting, professional, helpful and friendly staff across the board."	"I thought the Hamburg ELA event was a huge success and had similar feedback from a number of colleagues."	"ELA 2011 was a successful show for Venomtech, as there was a near constant stream of delegates in the exhibition area. The lead up to the event was well organised and I found it easy to get all the information I needed from the Select Biosciences staff."
European Lab Automation	European Lab Automation	European Lab Automation
TAP Biosystems	Dr. Till T. Bachmann, University of Edinburgh	Venomtech

Conference News

5 Reasons Not to Miss ELA 2013
We understand that staying up-to-date on the latest technologies boosting efficiency and effectiveness in the lab can be challenging. That’s exactly why we created ELA. Our latest blog entry - http://bit.ly/15HpwvN - highlights five key reasons not to miss this year’s event, all based on feedback we’ve received from past attendees.

The future of HCA using primary cells and 3D culture
This week’s ELA blog - http://bit.ly/15HpwvN -discusses the impact of process optimisation on cell based assays, with particular reference to High Content Analysis (HCA). To give us the inside scoop, we chatted with Dr Anthony Davies, Director of the High Content Research Facility at the Irish National Center for High Content Screening and Analysis (INCHSA) at Trinity College, Dublin, about the impact automation has had on the workflow at INCHSA. Dr Davies will also be sharing his expertise at E

Standards Make High-Content Screening Data More Powerful.....An Interview with Dr Stephan Schürer
Dr Stephan Schürer from the University of Miami speaks about the goals of the BioAssay Ontology Project to enable standardized description, integration and meta-analysis of assay and screening results - http://bit.ly/15HpwvN Dr Schürer will be discussing this topic in more detail at ELA 2013 as part of the Drug Discovery Automation track - http://bit.ly/16jbuPq

The ethics around biobanking – an interview with Zubin Master
This week’s blog focusses on the ethical issues surrounding biobanking, based on a recent interview we conducted with Zubin Master. Dr Master, Assistant Professor at the Alden March Bioethics Institute of Albany Medical College, will be discussing this topic in detail at ELA 2013 as part of his presentation, “Biobanks: Consent, Consensus & Public Trust.”

Optimising NGS workflows – an interview with Dr Mike Quail, Team Leader at the Sanger Institute
In this week's blog entry - http://bit.ly/15HpwvN - Dr Quail gives us some insight into the current advances being made in NGS, as well as some of the challenges still facing the optimisation of NGS pipelines. Dr Quail will be speaking at ELA 2013 about the new NGS applications being developed at the Sanger Institute, as well as some of improvements his team are making to sequencing protocols.

Trends at the forefront of liquid handling and lab automation
This week we caught up with Joe Liscouski, Executive Director at the Institute for Laboratory Automation (ILA) in MA, USA, to find out more about how the use of liquid handling has evolved over the last decade and to gain some insight into what we can expect next.